Increased Scrutiny of Opioids By FDA Could Alter Prescribing Practice

MedPage Today -- GAITHERSBURG, Md., May 28 -- If a formal risk reduction plan for opioid painkillers increases the regulatory burden on physicians, they may simply stop prescribing such drugs, to the detriment of patients in severe pain, the FDA was told Thursday.